CCM
QCOR

Cupps Capital Management’s QUESTCOR PHARMA INC QCOR Stock Holding History

Cupps Capital Management’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-46
Closed -$2K – 197
2013
Q3 		$2K Buy
+46
New +$2.73K ﹤0.01% 180

Other funds holding QCOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cupps Capital Management's QCOR Position: Q4 2013 in Review

Cupps Capital Management sold out of QUESTCOR PHARMA INC (QCOR) in Q4 2013, closing a stake of 46 shares — an estimated $2K sold.

Cupps Capital Management first reported a position in QCOR in Q3 2013 and held it in 1 quarter. The position peaked at $2K in Q3 2013. 285 funds tracked by Wall St. Rank hold QCOR as of Q4 2013.

  • Cupps Capital Management reported no remaining QUESTCOR PHARMA INC position as of Q4 2013 after selling out during the quarter.
  • Cupps Capital Management sold 46 QUESTCOR PHARMA INC shares in Q4 2013, an estimated $2K.
  • Cupps Capital Management first reported a position in QUESTCOR PHARMA INC in Q3 2013 and held it in 1 quarter.
  • Cupps Capital Management's QUESTCOR PHARMA INC position peaked at $2K in Q3 2013.
  • 285 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q4 2013.

Based on Cupps Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.